What physical exam findings might you expect if the patient had peripheral vascular disease include arterial and venous findings?

1. Fowkes F GR, Rudan D, Rudan Iet al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 2013382(9901):1329–1340. [PubMed] [Google Scholar]

2. Mozaffarian D, Benjamin E J, Go A S et al. Heart Disease and Stroke Statistics-2016 Update: a report from the American Heart Association. Circulation. 2016;133(04):e38–e360. [PubMed] [Google Scholar]

3. Subherwal S, Patel M R, Kober L et al. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study. Eur J Prev Cardiol. 2015;22(03):317–325. [PubMed] [Google Scholar]

4. Caro J, Migliaccio-Walle K, Ishak K J, Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord. 2005;5(01):14. [PMC free article] [PubMed] [Google Scholar]

5. Fowkes F G. Epidemiology of atherosclerotic arterial disease in the lower limbs. Eur J Vasc Surg. 1988;2(05):283–291. [PubMed] [Google Scholar]

6. Fowkes F GR, Aboyans V, Fowkes F JI, McDermott M M, Sampson U KA, Criqui M H. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol. 2017;14(03):156–170. [PubMed] [Google Scholar]

7. Gerhard-Herman M D, Gornik H L, Barrett C et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(11):e71–e126. [PubMed] [Google Scholar]

8. Berger J, Davies M, Clement D . Waltham, MA: UpToDate; 2018. Overview of lower extremity peripheral artery disease. [Google Scholar]

9. Neschis D, Golden M, Eidt J . Waltham, MA: UpToDate; 2018. Clinical features and diagnosis of lower extremity peripheral artery disease. [Google Scholar]

10. Bailey M A, Griffin K J, Scott D J. Clinical assessment of patients with peripheral arterial disease. Semin Intervent Radiol. 2014;31(04):292–299. [PMC free article] [PubMed] [Google Scholar]

11. Schainfeld R M. Management of peripheral arterial disease and intermittent claudication. J Am Board Fam Pract. 2001;14(06):443–450. [PubMed] [Google Scholar]

12. Edinburgh Claudication Questionnaire. Occas Pap R Coll Gen Pract. 2002;82:44. [Google Scholar]

13. McDermott M M. Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia. Circ Res. 2015;116(09):1540–1550. [PMC free article] [PubMed] [Google Scholar]

14. McDermott M M, Greenland P, Liu K et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286(13):1599–1606. [PubMed] [Google Scholar]

15. McDermott M M, Liu K, Greenland P et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004;292(04):453–461. [PubMed] [Google Scholar]

16. McDermott M M, Ferrucci L, Liu K et al. Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc. 2010;58(07):1256–1262. [PMC free article] [PubMed] [Google Scholar]

17. Collins T C, Petersen N J, Suarez-Almazor M. Peripheral arterial disease symptom subtype and walking impairment. Vasc Med. 2005;10(03):177–183. [PubMed] [Google Scholar]

18. Criqui M H, Denenberg J O, Bird C E, Fronek A, Klauber M R, Langer R D. The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996;1(01):65–71. [PubMed] [Google Scholar]

19. Gardner A W, Montgomery P S, Afaq A. Exercise performance in patients with peripheral arterial disease who have different types of exertional leg pain. J Vasc Surg. 2007;46(01):79–86. [PMC free article] [PubMed] [Google Scholar]

20. Wang J C, Criqui M H, Denenberg J O et al. Exertional leg pain in patients with and without peripheral arterial disease. Circulation. 2005;112(22):3501–3508. [PMC free article] [PubMed] [Google Scholar]

21. Norgren L, Hiatt W R, Dormandy J A et al. Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg. 2007;45:S5–S67. [PubMed] [Google Scholar]

22. Mills J, Eidt J, Kathryn C. Waltham, MA: UpToDate; 2018. Classification of acute and chronic lower extremity ischemia. [Google Scholar]

23. Bradbury A, Callum K.ABC of arterial and venous disease: Acute limb ischemia BMJ 2000320(7237):764–767. [PMC free article] [PubMed] [Google Scholar]

24. Gerhard-Herman M D, Gornik H L, Barrett C et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135(12):e686–e725. [PMC free article] [PubMed] [Google Scholar]

25. Hardman R L, Jazaeri O, Yi J, Smith M, Gupta R. Overview of classification systems in peripheral artery disease. Semin Intervent Radiol. 2014;31(04):378–388. [PMC free article] [PubMed] [Google Scholar]

26. Mills J L, Sr, Conte M S, Armstrong D G et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI) J Vasc Surg. 2014;59(01):220–34.e1, 2. [PubMed] [Google Scholar]

27. Zhan L X, Branco B C, Armstrong D G, Mills J L., Sr The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing. J Vasc Surg. 2015;61(04):939–944. [PubMed] [Google Scholar]

28. Al-Qaisi M, Nott D M, King D H, Kaddoura S. Ankle brachial pressure index (ABPI): an update for practitioners. Vasc Health Risk Manag. 2009;5:833–841. [PMC free article] [PubMed] [Google Scholar]

29. McPhail I R, Spittell P C, Weston S A, Bailey K R. Intermittent claudication: an objective office-based assessment. J Am Coll Cardiol. 2001;37(05):1381–1385. [PubMed] [Google Scholar]

30. Mitchell E, Eidt J, Mills J . Waltham, MA: UpToDate; 2018. Noninvasive diagnosis of arterial disease. [Google Scholar]

31. Carter S A, Tate R B. Value of toe pulse waves in addition to systolic pressures in the assessment of the severity of peripheral arterial disease and critical limb ischemia. J Vasc Surg. 1996;24(02):258–265. [PubMed] [Google Scholar]

32. Vitti M J, Robinson D V, Hauer-Jensen M et al. Wound healing in forefoot amputations: the predictive value of toe pressure. Ann Vasc Surg. 1994;8(01):99–106. [PubMed] [Google Scholar]

33. Apelqvist J, Castenfors J, Larsson J, Stenström A, Agardh C D. Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care. 1989;12(06):373–378. [PubMed] [Google Scholar]

34. Fife C E, Smart D R, Sheffield P J, Hopf H W, Hawkins G, Clarke D. Transcutaneous oximetry in clinical practice: consensus statements from an expert panel based on evidence. Undersea Hyperb Med. 2009;36(01):43–53. [PubMed] [Google Scholar]

35. Arsenault K A, McDonald J, Devereaux P J, Thorlund K, Tittley J G, Whitlock R P. The use of transcutaneous oximetry to predict complications of chronic wound healing: a systematic review and meta-analysis. Wound Repair Regen. 2011;19(06):657–663. [PubMed] [Google Scholar]

36. Castronuovo J J, Jr, Adera H M, Smiell J M, Price R M. Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia. J Vasc Surg. 1997;26(04):629–637. [PubMed] [Google Scholar]

37. Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. BioMed Res Int. 2014;2014:741018. [PMC free article] [PubMed] [Google Scholar]

38. Stacul F, van der Molen A J, Reimer P et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21(12):2527–2541. [PubMed] [Google Scholar]

39. Zhang B, Liang L, Chen W, Liang C, Zhang S. An updated study to determine association between gadolinium-based contrast agents and nephrogenic systemic fibrosis. PLoS One. 2015;10(06):e0129720. [PMC free article] [PubMed] [Google Scholar]

40. Nicolaï S P, Hendriks E J, Prins M H, Teijink J A; EXITPAD Study Group.Optimizing supervised exercise therapy for patients with intermittent claudication J Vasc Surg 201052051226–1233. [PubMed] [Google Scholar]

41. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.Heart Outcomes Prevention Evaluation Study Investigators;Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 200034203145–153. [PubMed] [Google Scholar]

42. Yusuf S, Teo K K, Pogue J.ONTARGET Investigators;et al. Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 2008358151547–1559. [PubMed] [Google Scholar]

43. Aboyans V, Ricco J B, Bartelink M EL et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J. 2018;39(09):763–816. [PubMed] [Google Scholar]

44. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J. 2013;34(28):2159–2219. [PubMed] [Google Scholar]

45. Whelton P, Carey R, Aronow R et al. Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2017;2017:24430. [PubMed] [Google Scholar]

46. Aung P P, Maxwell H G, Jepson R G, Price J F, Leng G C. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev. 2007;(04):CD000123. [PMC free article] [PubMed] [Google Scholar]

47. Antoniou G A, Fisher R K, Georgiadis G S, Antoniou S A, Torella F. Statin therapy in lower limb peripheral arterial disease: systematic review and meta-analysis. Vascul Pharmacol. 2014;63(02):79–87. [PubMed] [Google Scholar]

48. Heart Protection Study Collaborative Group.Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions J Vasc Surg 20074504645–654., discussion 653–654 [PubMed] [Google Scholar]

49. Stone N J, Robinson J G, Lichtenstein A H et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25) 02:S1–S45. [PubMed] [Google Scholar]

50. Singh S, Armstrong E J, Sherif W et al. Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty. Vasc Med. 2014;19(04):307–314. [PMC free article] [PubMed] [Google Scholar]

51. Takahara M, Kaneto H, Iida O et al. The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia. Diabetes Care. 2010;33(12):2538–2542. [PMC free article] [PubMed] [Google Scholar]

52. Antithrombotic Trialists' Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 2002324(7329):71–86. [PMC free article] [PubMed] [Google Scholar]

53. Berger J S, Krantz M J, Kittelson J M, Hiatt W R. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA. 2009;301(18):1909–1919. [PubMed] [Google Scholar]

54. CAPRIE Steering Committee.A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 1996348(9038):1329–1339. [PubMed] [Google Scholar]

55. Tepe G, Bantleon R, Brechtel K et al. Management of peripheral arterial interventions with mono or dual antiplatelet therapy--the MIRROR study: a randomised and double-blinded clinical trial. Eur Radiol. 2012;22(09):1998–2006. [PubMed] [Google Scholar]

56. Strobl F F, Brechtel K, Schmehl J et al. Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease. J Endovasc Ther. 2013;20(05):699–706. [PubMed] [Google Scholar]

57. Belch J J, Dormandy J et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010;52(04):825–833. [PubMed] [Google Scholar]

58. Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis D P, Stansby G. Cilostazol for intermittent claudication. Cochrane Database Syst Rev. 2014;10(10):CD003748. [PMC free article] [PubMed] [Google Scholar]

59. Murphy T P, Cutlip D E, Regensteiner J G et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125(01):130–139. [PMC free article] [PubMed] [Google Scholar]

60. Fakhry F, Rouwet E V, den Hoed P T, Hunink M G, Spronk S. Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. Br J Surg. 2013;100(09):1164–1171. [PubMed] [Google Scholar]

61. Murphy T P, Cutlip D E, Regensteiner J G et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015;65(10):999–1009. [PMC free article] [PubMed] [Google Scholar]

62. Shishehbor M H, White C J, Gray B H et al. Critical limb ischemia: an expert statement. J Am Coll Cardiol. 2016;68(18):2002–2015. [PubMed] [Google Scholar]

63. Clark N, Sheehan P, Edmonds M et al. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333–3341. [PubMed] [Google Scholar]

64. Hirsch A T, Haskal Z J, Hertzer N R et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–e654. [PubMed] [Google Scholar]

65. Leng G C, Lee A J, Fowkes F G et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25(06):1172–1181. [PubMed] [Google Scholar]

66. Dormandy J, Mahir M, Ascady G et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 1989;30(01):50–57. [PubMed] [Google Scholar]

67. Jelnes R, Gaardsting O, Hougaard Jensen K, Baekgaard N, Tønnesen K H, Schroeder T.Fate in intermittent claudication: outcome and risk factors Br Med J (Clin Res Ed) 1986293(6555):1137–1140. [PMC free article] [PubMed] [Google Scholar]

68. Bloor K. Natural history of arteriosclerosis of the lower extremities: Hunterian lecture delivered at the Royal College of Surgeons of England on 22nd April 1960. Ann R Coll Surg Engl. 1961;28(01):36–52. [PMC free article] [PubMed] [Google Scholar]

69. Zaetta J, Baum R, Cutlip D . Waltham, MA: UpToDate; 2018. Percutaneous interventional procedures in the patient with lower extremity claudication. [Google Scholar]

70. Creager M A, Belkin M, Bluth E I et al. 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular disease) J Am Coll Cardiol. 2012;59(03):294–357. [PubMed] [Google Scholar]

71. Rutherford R B, Baker J D, Ernst C et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(03):517–538. [PubMed] [Google Scholar]

72. Blaisdell F W. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg. 2002;10(06):620–630. [PubMed] [Google Scholar]

73. Comerota A J, Weaver F A, Hosking J D et al. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am J Surg. 1996;172(02):105–112. [PubMed] [Google Scholar]

74. Ouriel K, Veith F J, Sasahara A A; Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs N Engl J Med 1998338161105–1111. [PubMed] [Google Scholar]

75. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial Ann Surg 199422003251–266., discussion 266–268 [PMC free article] [PubMed] [Google Scholar]

76. Ouriel K, Shortell C K, DeWeese J A et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg. 1994;19(06):1021–1030. [PubMed] [Google Scholar]

77. Gupta R, Hennebry T A. Percutaneous isolated pharmaco-mechanical thrombolysis-thrombectomy system for the management of acute arterial limb ischemia: 30-day results from a single-center experience. Catheter Cardiovasc Interv. 2012;80(04):636–643. [PubMed] [Google Scholar]

78. Silva J A, Ramee S R, Collins T J et al. Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators. Cathet Cardiovasc Diagn. 1998;45(04):386–393. [PubMed] [Google Scholar]

79. Taha A G, Byrne R M, Avgerinos E D, Marone L K, Makaroun M S, Chaer R A. Comparative effectiveness of endovascular versus surgical revascularization for acute lower extremity ischemia. J Vasc Surg. 2015;61(01):147–154. [PubMed] [Google Scholar]

80. Leung D A, Blitz L R, Nelson T et al. Rheolytic pharmacomechanical thrombectomy for the management of acute limb ischemia: results from the PEARL registry. J Endovasc Ther. 2015;22(04):546–557. [PubMed] [Google Scholar]

81. Nelson J A. Compartment pressure measurements have poor specificity for compartment syndrome in the traumatized limb. J Emerg Med. 2013;44(05):1039–1044. [PubMed] [Google Scholar]

82. Stracciolini A, Hammerberg M, Moreira M, Bachur R, Grayzie J. Waltham, MA: UpToDate; 2018. Acute compartment syndrome of the extremities. [Google Scholar]

83. Bekwelem W, Connolly S J, Halperin J L et al. Extracranial systemic embolic events in patients with nonvalvular atrial fibrillation: incidence, risk factors, and outcomes. Circulation. 2015;132(09):796–803. [PubMed] [Google Scholar]

84. Abu Dabrh A M, Steffen M W, Undavalli C et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015;62(06):1642–51000. [PubMed] [Google Scholar]

85. AbuRahma A F, Robinson P A, Holt S M.Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses Surgery 199912604594–601., discussion 601–602 [PubMed] [Google Scholar]

86. Green R M, Abbott W M, Matsumoto T et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg. 2000;31(03):417–425. [PubMed] [Google Scholar]

87. Klinkert P, Schepers A, Burger D H, van Bockel J H, Breslau P J. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003;37(01):149–155. [PubMed] [Google Scholar]

88. Johnson W C, Lee K K. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg. 2000;32(02):268–277. [PubMed] [Google Scholar]

89. Nolan B W, De Martino R R, Stone D Het al. Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass J Vasc Surg 20115403730–735., discussion 735–736 [PMC free article] [PubMed] [Google Scholar]

90. Santo V J, Dargon P, Azarbal A F et al. Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure. J Vasc Surg. 2014;60(01):129–135. [PubMed] [Google Scholar]

91. Uhl C, Hock C, Betz T, Töpel I, Steinbauer M. Pedal bypass surgery after crural endovascular intervention. J Vasc Surg. 2014;59(06):1583–1587. [PubMed] [Google Scholar]

92. Gray B H, Laird J R, Ansel G M, Shuck J W. Complex endovascular treatment for critical limb ischemia in poor surgical candidates: a pilot study. J Endovasc Ther. 2002;9(05):599–604. [PubMed] [Google Scholar]

93. Ryer E J, Trocciola S M, DeRubertis B et al. Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. Ann Vasc Surg. 2006;20(04):440–446. [PubMed] [Google Scholar]

94. Nishibe T, Maruno K, Iwahori A et al. The role of common femoral artery endarterectomy in the endovascular era. Ann Vasc Surg. 2015;29(08):1501–1507. [PubMed] [Google Scholar]

95. Okadome J, Matsumoto T, Aoyagi Y et al. Long-term results of a hybrid revascularization procedure for peripheral arterial disease. Fukuoka Igaku Zasshi. 2015;106(09):254–261. [PubMed] [Google Scholar]

96. Starodubtsev V, Karpenko A, Ignatenko P. Hybrid and open surgery of Trans-Atlantic Inter-Society II type C and D iliac occlusive disease and concomitant lesion of common femoral artery. Int Angiol. 2016;35(05):484–491. [PubMed] [Google Scholar]

97. Adam D J, Beard J D, Cleveland Tet al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial Lancet 2005366(9501):1925–1934. [PubMed] [Google Scholar]

98. Bradbury A W, Adam D J, Bell Jet al. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial Health Technol Assess 201014141–210., iii–iv [PubMed] [Google Scholar]

99. Fogle M A, Whittemore A D, Couch N P, Mannick J A. A comparison of in situ and reversed saphenous vein grafts for infrainguinal reconstruction. J Vasc Surg. 1987;5(01):46–52. [PubMed] [Google Scholar]

100. Leather R P, Karmody A M. In-situ saphenous vein arterial bypass for the treatment of limb ischemia. Adv Surg. 1986;19:175–219. [PubMed] [Google Scholar]

101. Taylor L M, Jr, Edwards J M, Porter J M.Present status of reversed vein bypass grafting: five-year results of a modern series J Vasc Surg 19901102193–205., discussion 205–206 [PubMed] [Google Scholar]

102. Alexandrescu V, Söderström M, Venermo M. Angiosome theory: fact or fiction? Scand J Surg. 2012;101(02):125–131. [PubMed] [Google Scholar]

103. Bosanquet D C, Glasbey J C, Williams I M, Twine C P. Systematic review and meta-analysis of direct versus indirect angiosomal revascularisation of infrapopliteal arteries. Eur J Vasc Endovasc Surg. 2014;48(01):88–97. [PubMed] [Google Scholar]

104. Biancari F, Juvonen T. Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2014;47(05):517–522. [PubMed] [Google Scholar]

105. Baker J D, Dix D E. Variability of Doppler ankle pressures with arterial occlusive disease: an evaluation of ankle index and brachial-ankle pressure gradient. Surgery. 1981;89(01):134–137. [PubMed] [Google Scholar]

106. Back M R, Novotney M, Roth S M et al. Utility of duplex surveillance following iliac artery angioplasty and primary stenting. J Endovasc Ther. 2001;8(06):629–637. [PubMed] [Google Scholar]

107. Baril D T, Marone L K. Duplex evaluation following femoropopliteal angioplasty and stenting: criteria and utility of surveillance. Vasc Endovascular Surg. 2012;46(05):353–357. [PubMed] [Google Scholar]

108. Troutman D A, Madden N J, Dougherty M J, Calligaro K D. Duplex ultrasound diagnosis of failing stent grafts placed for occlusive disease. J Vasc Surg. 2014;60(06):1580–1584. [PubMed] [Google Scholar]

109. Lundell A, Lindblad B, Bergqvist D, Hansen F.Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study J Vasc Surg 1995210126–33., discussion 33–34 [PubMed] [Google Scholar]

110. Brumberg R S, Back M R, Armstrong P A et al. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure. J Vasc Surg. 2007;46(06):1160–1166. [PubMed] [Google Scholar]

111. Calligaro K D, Doerr K, McAffee-Bennett S, Krug R, Raviola C A, Dougherty M J. Should duplex ultrasonography be performed for surveillance of femoropopliteal and femorotibial arterial prosthetic bypasses? Ann Vasc Surg. 2001;15(05):520–524. [PubMed] [Google Scholar]

112. Stone P A, Armstrong P A, Bandyk D F et al. Duplex ultrasound criteria for femorofemoral bypass revision. J Vasc Surg. 2006;44(03):496–502. [PubMed] [Google Scholar]

What are the typical symptoms of peripheral arterial disease?

What is the classic symptom of patients with peripheral arterial disease?

What physical assessment findings should the nurse anticipate when examining a patient with peripheral artery disease in a lower extremity?

What is the most common presentation of peripheral arterial disease?